Can metronidazole topical gel or cream be applied to the face?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Metronidazole Gel or Cream Be Used on the Face?

Yes, metronidazole topical gel and cream are specifically designed for and FDA-approved for facial application, particularly for treating rosacea. 1

Primary Indication and Application Site

Metronidazole topical formulations (0.75% and 1.0% concentrations in gel, cream, and lotion forms) have been used as a mainstay of facial rosacea therapy since 1989. 1 The medication is specifically formulated for facial application and has been extensively studied in split-face trials where patients applied the medication to one side of their face, demonstrating both its intended use and safety profile for facial skin. 1

Evidence for Facial Use

Clinical Trial Data

  • Multiple formulations tested on facial skin: Studies involving over 500 patients have demonstrated the safety and efficacy of metronidazole 0.75% and 1.0% formulations applied to the face. 1
  • Split-face studies confirm facial tolerability: A 9-week study had 40 adults apply metronidazole 0.75% twice daily to one side of their face, producing a 65% decrease in inflammatory lesion counts with good tolerability. 1
  • Long-term facial use is safe: A 6-month double-blind placebo-controlled study confirmed long-term efficacy and safety of metronidazole as monotherapy for facial inflammatory lesions associated with rosacea. 1

Cosmetic Compatibility

Metronidazole gel 1% can be safely used under facial foundation cosmetics without compromising appearance or worsening rosacea symptoms. 2 In a study of 28 participants who applied their usual facial foundation after metronidazole gel 1%, both investigators and participants rated cosmetic appearance as excellent (median score of 10/10), and rosacea symptoms did not worsen. 2

Recommended Application

For rosacea treatment: Apply metronidazole 0.75% twice daily or 1.0% once daily to the entire face after cleansing with a gentle cleanser. 1, 3 Both concentrations are equally effective when metronidazole 1.0% is used once daily. 1, 3

Safety Considerations for Facial Use

While topical metronidazole is generally well-tolerated on facial skin, be aware of:

  • Mild local irritation: Dryness, scaling, and mild stinging/burning may occur but are typically reversible. 2
  • Severe cutaneous adverse reactions (SCARs): Though rare, toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), DRESS, and AGEP have been reported with metronidazole use. 4 Discontinue immediately if severe skin reactions develop.
  • Hypersensitivity reactions: Can be serious and potentially life-threatening. 4

Clinical Context

According to the 2024 treatment landscape review, metronidazole remains an FDA-approved first-line topical option for mild to moderate inflammatory papules and pustules of rosacea, though newer agents like ivermectin 1% cream have shown superior efficacy in head-to-head comparisons. 1 The 2017 ROSCO panel consensus guidelines list metronidazole (topical) as a first-line treatment option for mild inflammatory rosacea affecting the face. 5

Important caveat: The evidence provided relates specifically to topical formulations (gel, cream, lotion) designed for dermatologic use. Oral metronidazole formulations are not intended for topical facial application. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.